Abstract |
The cell surface receptor, low-density lipoprotein receptor-related protein 5 (LRP5) is a key regulator of bone mass. Loss-of-function mutations in LRP5 cause the human skeletal disease osteoporosis-pseudoglioma syndrome, an autosomal recessive disorder characterized by severely reduced bone mass and strength. We investigated the role of LRP5 on bone strength using mice engineered with a loss-of-function mutation in the gene. We then tested whether the osteogenic response to mechanical loading was affected by the loss of Lrp5 signaling. Lrp5-null (Lrp5-/-) mice exhibited significantly lower bone mineral density and decreased strength. The osteogenic response to mechanical loading of the ulna was reduced by 88 to 99% in Lrp5-/- mice, yet osteoblast recruitment and/or activation at mechanically strained surfaces was normal. Subsequent experiments demonstrated an inability of Lrp5-/- osteoblasts to synthesize the bone matrix protein osteopontin after a mechanical stimulus. We then tested whether Lrp5-/- mice increased bone formation in response to intermittent parathyroid hormone (PTH), a known anabolic treatment. A 4-week course of intermittent PTH (40 microg/kg/day; 5 days/week) enhanced skeletal mass equally in Lrp5-/- and Lrp5+/+ mice, suggesting that the anabolic effects of PTH do not require Lrp5 signaling. We conclude that Lrp5 is critical for mechanotransduction in osteoblasts. Lrp5 is a mediator of mature osteoblast function following loading. Our data suggest an important component of the skeletal fragility phenotype in individuals affected with osteoporosis-pseudoglioma is inadequate processing of signals derived from mechanical stimulation and that PTH might be an effective treatment for improving bone mass in these patients.
|
Authors | Kimihiko Sawakami, Alexander G Robling, Minrong Ai, Nathaniel D Pitner, Dawei Liu, Stuart J Warden, Jiliang Li, Peter Maye, David W Rowe, Randall L Duncan, Matthew L Warman, Charles H Turner |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 281
Issue 33
Pg. 23698-711
(Aug 18 2006)
ISSN: 0021-9258 [Print] United States |
PMID | 16790443
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Anabolic Agents
- LDL-Receptor Related Proteins
- LRP5 protein, human
- Low Density Lipoprotein Receptor-Related Protein-5
- Lrp5 protein, mouse
- Parathyroid Hormone
- Peptide Fragments
- Wnt Proteins
|
Topics |
- Anabolic Agents
(administration & dosage)
- Animals
- Body Weight
(genetics)
- Bone Density
(genetics)
- Bone Remodeling
(genetics)
- Bone and Bones
(cytology, metabolism, physiology)
- Cell Movement
(genetics)
- Cells, Cultured
- Female
- Humans
- LDL-Receptor Related Proteins
(deficiency, genetics, physiology)
- Low Density Lipoprotein Receptor-Related Protein-5
- Male
- Mechanotransduction, Cellular
(genetics, physiology)
- Mice
- Mice, Knockout
- Mice, Transgenic
- Osteoblasts
(metabolism, physiology)
- Osteogenesis
(genetics)
- Parathyroid Hormone
(administration & dosage)
- Peptide Fragments
(administration & dosage)
- Wnt Proteins
(metabolism)
|